Coherus BioSciences Investor Relations Material
Latest events
Q4 2023
Coherus BioSciences
Access the full event backlog
Slides, Transcripts, and Reports from 9,000+ public companies
Latest reports from Coherus BioSciences Inc
Access all reports
Coherus BioSciences, Inc., a biopharmaceutical company, focuses on the biosimilar and immuno-oncology market primarily in the United States. The company seeks to create rationally designed molecules for important therapeutic targets that have been the targets of drugs or biological products that are either currently approved or in clinical development for inflammatory, metabolic, autoimmune/lupus, nephrology and cardiovascular/vascular diseases. Coherus BioSciences was founded in 2010 and is headquartered in Redwood City, California.
Key slides for Coherus BioSciences Inc
J.P. Morgan 42nd Annual Healthcare Conference 2024
Coherus BioSciences Inc
J.P. Morgan 42nd Annual Healthcare Conference 2024
Coherus BioSciences Inc
Latest articles
Sundar Pichai: CEO of Alphabet and Google
Explore Sundar Pichai's improbable journey from Chennai, India, to becoming one of the most powerful individuals on the planet.
19 Apr 2024
The Three Cornerstones of Serial Acquirer Success
Explore what is behind successful serial acquirers: efficient capital use, decentralization, and a strong focus on people.
19 Apr 2024
Companies That Had Their IPO in 2023: Cautious Optimism
The cautiously optimistic market in 2023 saw stocks rebounded upwards, and interest in IPOs picked up from the previous year.
15 Apr 2024
Ticker symbol
Country
🇺🇸 United States